The Despatch Trial: DElivering Stroke Prevention for patients with ATrial fibrillation: a Cluster randomised controlled trial in a primary Health care setting.

Not Applicable

Completed

• Conditions: Atrial Fibrillation; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12608000074392
• Lead Sponsor: HMRC

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-02-08
• Study Completion: 2010-10-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1116

Inclusion Criteria

This is a cluster randomised controlled trial with general practices designated the unit of randomisation. Outcome measures will be assessed using patient data derived from medical records.

1) GPs with a practice location within Sydney Metropolitan Area.
2) GPs must utilise an electronic data-base for issuing prescriptions and recording patient information (sex, age, contact details).

Inclusion criteria for patients:
1) Aged older than 65 years
2) Ability to provide consent for medical record audit.

Exclusion Criteria

Exclusion criteria for GPs:

GPs engaged primarily in special interest practice with limited contact of elderly patients (> 65 years of age) will be considerd ineligible to participate.

GPs in part-time practice (2 days a week or less) will initially be considered ineligible. However, this ineligibility criterion will be reviewed depending on the rate of recruitment of GPs and feasibility of recruitment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of patients over the age of 65 with a diagnosis of atrial fibrillation who have been prescribed warfarin.[1) Note of a prescription at any time during the 12-months after GP randomisation. <br>2) Note of a prescription current at 12-months post-randomisation]